First Trust Advisors
AVXL icon

First Trust Advisors’s Anavex Life Sciences AVXL Stock Holding History

First Trust Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-177,823
Closed -$4.07M – 2518
2021
Q2 		$4.07M Sell
177,823
-4,966
-3% -$73.6K ﹤0.01% 1476
2021
Q1 		$2.73M Buy
182,789
+37,164
+26% +$406K ﹤0.01% 1602
2020
Q4 		$786K Sell
145,625
-6,582
-4% -$34.7K ﹤0.01% 1988
2020
Q3 		$693K Buy
+152,207
New +$655K ﹤0.01% 1914

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

First Trust Advisors's AVXL Position: Q3 2021 in Review

First Trust Advisors sold out of Anavex Life Sciences (AVXL) in Q3 2021, closing a stake of 177,823 shares — an estimated $4.07M sold.

First Trust Advisors first reported a position in AVXL in Q3 2020 and held it in 4 quarters. The position peaked at $4.07M in Q2 2021. 136 funds tracked by Wall St. Rank hold AVXL as of Q3 2021.

  • First Trust Advisors reported no remaining Anavex Life Sciences position as of Q3 2021 after selling out during the quarter.
  • First Trust Advisors sold 177,823 Anavex Life Sciences shares in Q3 2021, an estimated $4.07M.
  • First Trust Advisors first reported a position in Anavex Life Sciences in Q3 2020 and held it in 4 quarters.
  • First Trust Advisors's Anavex Life Sciences position peaked at $4.07M in Q2 2021.
  • 136 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2021.

Based on First Trust Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.